🇺🇸 Ginkgobiloba in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Interaction — 2 reports (18.18%)
  2. Cerebrovascular Accident — 1 report (9.09%)
  3. Chest Pain — 1 report (9.09%)
  4. Coronary Arterial Stent Insertion — 1 report (9.09%)
  5. Depression — 1 report (9.09%)
  6. Dermal Cyst — 1 report (9.09%)
  7. Drug Dose Omission — 1 report (9.09%)
  8. Drug Ineffective — 1 report (9.09%)
  9. Dyspnoea — 1 report (9.09%)
  10. Entropion — 1 report (9.09%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Ginkgobiloba approved in United States?

Ginkgobiloba does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Ginkgobiloba in United States?

Menoufia University is the originator. The local marketing authorisation holder may differ — check the official source linked above.